retatrutide side effects phase 2 trial experimental weight-loss drug and concerns Retatrutide FDA Approval Status 2026:

Other tiers you will see below: Moderate (one solid trial or a consistent real-world pattern), Emerging (early or contested signals), and Mechanistic Only (animal or lab work with no human data yet)

Completely agree with your framing: menopause is a metabolic inflection point, and outcomes are best when we treat the whole system, not one pathway in isolation

doi:10.1152/ajpendo.00269.2012

61 It is important to note that the several mechanisms through which GLP-1RAs exert their anti-inflammatory effects are intertwined and contribute to overall effect

Eli Lillys lack of transparency may have violated legal and ethical obligations, influencing patient treatment decisions